Wu X, Miyake K, Medina K L, Kincade P W, Gimble J M
Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
Hybridoma. 1994 Oct;13(5):409-16. doi: 10.1089/hyb.1994.13.409.
Previous studies with the rat monoclonal antibody KMI6 had localized its antigen in vivo to a discrete subpopulation of marrow stromal cells. The KMI6 antigen has now been identified as the murine homolog of integrin beta 1 by amino acid sequence analysis and by cross-reactivity with antiserum to the avian integrin beta 1. The relative tissue abundance of murine integrin beta 1 was determined by Western blot. Although immunoperoxidase staining of fixed murine hematopoietic tissues demonstrated an abundance of intracellular beta 1, few primary-derived cells of lymphohematopoietic origin were surface positive as assessed by immunofluorescence and flow cytometry. Fetal erythroblasts provided the only exception. In contrast, the antigen was readily detected on the surface of several cultured cell lines in association with a variety of alpha chains. The biochemical properties of the surface labeled murine integrin beta 1 were similar to those of its human counterpart, exhibiting an altered electrophoretic migration under reduced conditions or following N-glycanase treatment. The antibody recognition of the protein was insensitive to glycosylation state, presence of divalent cations, detergents, or transfer to a nitrocellulose membrane. However, on Western blot, the epitope was lost on reduction of the protein, suggesting that it is conformation dependent. These data indicate that although KMI6 epitope is widely distributed, its surface expression in vivo may be restricted within lymphohemopoietic tissues.
先前对大鼠单克隆抗体KMI6的研究已将其抗原在体内定位到骨髓基质细胞的一个离散亚群。通过氨基酸序列分析以及与抗禽整合素β1抗血清的交叉反应,现已确定KMI6抗原为整合素β1的小鼠同源物。通过蛋白质印迹法测定了小鼠整合素β1的相对组织丰度。尽管对固定的小鼠造血组织进行免疫过氧化物酶染色显示细胞内有大量的β1,但通过免疫荧光和流式细胞术评估,很少有淋巴造血起源的原代细胞表面呈阳性。胎儿成红细胞是唯一的例外。相比之下,在几种培养的细胞系表面很容易检测到该抗原,且与多种α链相关。表面标记的小鼠整合素β1的生化特性与其人类对应物相似,在还原条件下或经N - 糖苷酶处理后电泳迁移发生改变。该蛋白的抗体识别对糖基化状态、二价阳离子的存在、去污剂或转移至硝酸纤维素膜不敏感。然而,在蛋白质印迹上,该表位在蛋白质还原后消失,表明它依赖于构象。这些数据表明,尽管KMI6表位广泛分布,但其在体内的表面表达可能在淋巴造血组织内受到限制。